Learn More
Medchemexpress LLC 7-methoxy-4-((6-phenyl-1,2,4-triazolo[4,3-b]pyridazin-3-yl)methoxy)quinoline | 1002304-34-8 | 99.9% | 50 MG

Supplier: Medchemexpress LLC HY1203550MG
AMG-208 is an orally active small-molecule inhibitor of c-Met and RON tyrosine kinases used in preclinical cancer research. It demonstrates low-nanomolar biochemical potency against c-Met, cellular activity in cancer cell lines, and reported CYP3A4 inhibition. Supplied for laboratory research use only.
- Orally active c-Met and RON tyrosine kinase inhibitor
- Biochemical IC50 for c-Met ≈ 9 nM
- Cellular activity: inhibits c-Met autophosphorylation in prostate cancer cells (IC50 ≈ 46 nM)
- Reports CYP3A4 inhibition (IC50 ≈ 32 μM)
- High research-grade purity (≈99.9%)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.